Windtree Therapeutics New (WINT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,112 | -16,092 | -6,534 | -27,475 | -20,100 |
| Depreciation Amortization | 126 | 85 | 45 | 358 | 305 |
| Accounts receivable | -1,975 | N/A | N/A | N/A | -830 |
| Accounts payable and accrued liabilities | -982 | -485 | -307 | -2,468 | N/A |
| Other Working Capital | -1,840 | -1,236 | -859 | -6,705 | -5,085 |
| Other Operating Activity | 9,007 | 5,208 | 2,173 | 11,627 | 6,506 |
| Operating Cash Flow | $-20,776 | $-12,520 | $-5,482 | $-24,663 | $-19,204 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 13,988 | 13,988 |
| PPE Investments | -27 | -12 | N/A | -191 | -129 |
| Investing Cash Flow | $-27 | $-12 | $N/A | $13,797 | $13,859 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,947 | 1,547 | N/A | 1,000 | N/A |
| Debt Repayment | -3,424 | -746 | -199 | -2,063 | -820 |
| Common Stock Issued | 20,387 | 20,246 | N/A | 22,982 | N/A |
| Other Financing Activity | 0 | 0 | 0 | -151 | -151 |
| Financing Cash Flow | $19,910 | $21,047 | $-199 | $21,768 | $-971 |
| Exchange Rate Effect | 671 | 422 | -98 | 472 | -451 |
| Beginning Cash Position | 22,732 | 22,732 | 22,732 | 11,358 | 11,358 |
| End Cash Position | 22,510 | 31,669 | 16,953 | 22,732 | 4,591 |
| Net Cash Flow | $-222 | $8,937 | $-5,779 | $11,374 | $-6,767 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,776 | -12,520 | -5,482 | -24,663 | -19,204 |
| Capital Expenditure | -27 | -12 | N/A | -191 | -129 |
| Free Cash Flow | -20,803 | -12,532 | -5,482 | -24,854 | -19,333 |